Home > FTC Compliance

BREAKING NEWS: Second Circuit Chimes in on Nutraceutical Claim Substantiation

The Second Circuit recently breathed life back into a lawsuit about the adequacy of data used to support cognitive enhancement claims.  Specifically, the court vacated a previous Southern District of New York dismissal of an FTC complaint alleging that Quincy Bioscience advertised the memory supplement “Prevagen” without a reasonable basis

Read More

FTC Halts Stem Cell Claims

A California-based physician and the companies that he controls have settled charges by the Federal Trade Commission that “amniotic stem cell therapy” can treat serious diseases, such as Parkinson’s disease, autism, macular degeneration, cerebral palsy, multiple sclerosis and heart attacks. As set forth in the complaint, the defendants earned millions of

Read More

False Advertising Penalties Are a Matter of Degree

In the matter of United States v. Arif, the First Circuit considered the issue of when false advertising constitutes a crime. In Arif, Mustafa Hassan Arif conditionally pled guilty to wire fraud in 2016 for allegedly selling non-FDA approved prescription drug products that purported to treat or cure numerous diseases and

Read More